MedTrace Logo

A Pre-Cellular Therapy Observational Study in Early Huntington's Disease

NCT01937923 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2016-11-01

No results posted yet for this study

Summary

This observational study will establish a clinical baseline and measure changes over time in movement, thinking, behavior, brain imaging, blood and spinal fluid markers in subjects with early stage Huntington's disease. Participants enrolled in this study may be eligible to participate in a future planned study of stem cell therapy for Huntington's Disease (HD).

In-person study visits occur at screening, baseline, and every 6 months thereafter for a minimum of 12 months, with interim phone call assessments.

Conditions

  • Huntington Disease

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Vicki Wheelock, MD · University of California, Davis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01937923 on ClinicalTrials.gov